Leeds United will field a heavily rotated side for their FA Cup fourth round clash at home to Millwall on Saturday, Daniel ...

Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.

It will still be too easy to buy slimming jabs online using fake details, say prescribers after new rules come into force ...

If you want stocks that you can buy and hold for not only years, but potentially the rest of your life, it's important to ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has ...

There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as particularly promising.

Tori Spelling’s plastic surgery has left the audience stunned. The star has unveiled the secrets through podcasts and interviews and got the cat out of the bag.

Mounjaro and Zepbound, may change a person’s overall health. The study, published Monday in the journal Nature Medicine, is one of the first big-picture looks at the benefits and risks of these new ...

Shares of Eli Lilly & Co. were headed for their worst day in nearly four years on Tuesday after the drugmaker provided a fourth-quarter revenue outlook that was below expectations, citing slower ...